Blastic natural killer cell lymphoma/leukaemia in a cat

• Published in: JFMS open reports Vol. 5; no. 2; p. 2055116919863080
• Main Authors: Hirabayashi, Miyuki, Chambers, James K, Sugawara, Mei, Ohmi, Aki, Tsujimoto, Hajime, Nakayama, Hiroyuki, Uchida, Kazuyuki
• Format: Report
• Language: English
• Published: 01.07.2019
• ISSN: 2055-1169
• DOI: 10.1177/2055116919863080

CASE SUMMARYA 7-year-old mixed-breed cat presented with subcutaneous oedema and erythema extending from the right axilla to the abdomen. Fine-needle aspiration of the subcutaneous lesion revealed large, atypical, round cells. A clonality analysis for the T-cell receptor-gamma and immunoglobulin heavy chain genes showed no clonal rearrangement. The presumed diagnosis was lymphoma and the cat was treated with prednisolone and L-asparaginase but died 78 days after initial treatment. At necropsy, an oedematous subcutaneous mass in the right axilla, hepatomegaly, splenomegaly and lymphadenopathy of the mediastinum and left axilla were observed. Histopathological examination revealed diffuse infiltration of large atypical round cells in the subcutaneous mass, liver, spleen, lymph nodes and bone marrow. Immunohistochemically, the tumour cells were strongly positive for CD56, and negative for CD3, CD20, CD79a, CD57, granzyme B and perforin. Based on these findings, the cat was diagnosed with blastic natural killer (NK) cell lymphoma/leukaemia. RELEVANCE AND NOVEL INFORMATIONHere, we report the pathological and clinical findings of NK cell lymphoma/leukaemia in a cat. The antibody for human CD56, a diagnostic marker for human NK cell neoplasms, showed cross-reactivity with feline CD56 by immunohistochemistry and Western blotting analysis. The antibody could be a useful diagnostic marker for feline NK cell neoplasms.